ClinVar Miner

Submissions for variant NM_000484.4(APP):c.226G>A (p.Val76Ile)

gnomAD frequency: 0.00039  dbSNP: rs151188448
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Athena Diagnostics RCV001664518 SCV001880040 benign not specified 2021-03-30 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV002064847 SCV002417251 likely benign Alzheimer disease 2023-11-17 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV001664518 SCV005075793 likely benign not specified 2024-04-03 criteria provided, single submitter clinical testing Variant summary: APP c.226G>A (p.Val76Ile) results in a conservative amino acid change located in the amyloidogenic glycoprotein, extracellular domain (IPR008154) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant is located near a canonical splice site, yet consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 8.1e-05 in 1613912 control chromosomes, predominantly at a frequency of 0.0014 within the African or African-American subpopulation in the gnomAD database, including 1 homozygote, suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. c.226G>A has been reported in the literature in two individuals affected with Alzheimer Disease without strong evidence for causality and was also reported in a control individual (N'Songo_2017). This report does not provide unequivocal conclusions about association of the variant with Alzheimer Disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication has been ascertained in the context of this evaluation (PMID: 28106563). ClinVar contains an entry for this variant (Variation ID: 705909). Based on the evidence outlined above, the variant was classified as likely benign.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.